What does this research mean for the field?

Activation of renal tubular mitochondrial Akt1 protects against diabetic nephropathy progression and improves systemic glucose metabolism through a previously unrecognized crosstalk with pancreatic insulin secretion. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

To determine whether activating mitochondrial Akt1 in renal proximal tubules reverses diabetic nephropathy progression and modulates systemic glucose homeostasis.

August 27, 2026Journal of EndocrinologyOpen Access

Dual roles of renal tubular mitochondrial Akt1 in protecting against diabetic nephropathy and improving body glucose metabolism

View Full Paper

Ask AI

Bookmark

Authors

ESEsam S. B. Salem ATALBERT TA EBElizabeth Bloom-Saldana

Discussion

Member takes

Overview

Transgenic mouse study reveals that activating renal tubular mitochondrial Akt1 reverses diabetic kidney disease and enhances insulin secretion, suggesting a novel kidney-pancreas metabolic crosstalk.

Key Points

To determine whether activating mitochondrial Akt1 in renal proximal tubules reverses diabetic nephropathy progression and modulates systemic glucose homeostasis.
Generated transgenic mice (KMCAKT) with renal tubule-specific, tamoxifen-inducible, mitochondria-targeted constitutively active Akt1.
Induced type 2 diabetes by feeding mice a high-fat, high-fructose diet (HFFD) for 40 weeks, followed by renal histological, functional, and dynamic glucose evaluations including hyperglycemic clamps.
Tamoxifen-induced Akt1 activation significantly ameliorated kidney dysfunction and histology, reducing urinary albumin, fasting plasma BUN, fibrosis, Jablonski scores, α-smooth muscle actin, and TGFβ1 relative to controls.
Akt1-activated mice exhibited lower fasting blood glucose, improved oral glucose tolerance, increased beta cell mass, and higher basal and stimulated insulin secretion.

Cite This Study

Salem et al. (2026) studied this question.

synapsesocial.com/papers/6a8fea3310c91c1e926224f5 https://doi.org/10.1530/joe-26-0143

View Full Paper

Ask AI

Bookmark

August 27, 2026Journal of EndocrinologyOpen Access

Dual roles of renal tubular mitochondrial Akt1 in protecting against diabetic nephropathy and improving body glucose metabolism

View Full Paper

Ask AI

Bookmark

Authors

ESEsam S. B. Salem ATALBERT TA EBElizabeth Bloom-Saldana

Discussion

Member takes

Overview

Key Points

To determine whether activating mitochondrial Akt1 in renal proximal tubules reverses diabetic nephropathy progression and modulates systemic glucose homeostasis.
Generated transgenic mice (KMCAKT) with renal tubule-specific, tamoxifen-inducible, mitochondria-targeted constitutively active Akt1.
Induced type 2 diabetes by feeding mice a high-fat, high-fructose diet (HFFD) for 40 weeks, followed by renal histological, functional, and dynamic glucose evaluations including hyperglycemic clamps.
Tamoxifen-induced Akt1 activation significantly ameliorated kidney dysfunction and histology, reducing urinary albumin, fasting plasma BUN, fibrosis, Jablonski scores, α-smooth muscle actin, and TGFβ1 relative to controls.
Akt1-activated mice exhibited lower fasting blood glucose, improved oral glucose tolerance, increased beta cell mass, and higher basal and stimulated insulin secretion.

Cite This Study

Salem et al. (2026) studied this question.

synapsesocial.com/papers/6a8fea3310c91c1e926224f5 https://doi.org/10.1530/joe-26-0143

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark